Kentucky seeks $1bn from Purdue Pharma for misrepresenting addictive potential of oxycodone.
Montreal.
Owen
O
Dyer
D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007629:Kentucky / Q000453:epidemiology; D040541:Marketing / Q000331:legislation & jurisprudence*; D009294:Narcotics; D009293:Opioid-Related Disorders / Q000453:epidemiology; D010098:Oxycodone
D009294:Narcotics; D010098:Oxycodone